低分子肝素合用阿司匹林肠溶片治疗脑梗死患者DVT的临床观察

Clinical observation of low-molecular-weight heparin and aspirin enteric-coated tablets therapy on deep vein thrombosis

目的观察脑梗死患者下肢深静脉血栓形成后抗凝剂加血小板抑制剂的临床疗效。方法低分子肝素0.4ml皮下注射(腹部),1次/12h,疗程2周,合用阿司匹林肠溶片0.3g,1次/d。结果11例患者除1例发生皮下出血外均治愈或好转。结论抗凝与抗血小板聚集对脑梗死患者并发DVT治疗安全、有效。

Objective To study the clinical therapeutic efficacy of anticoagulation and anti -platelet aggregation activity for patients with cerebral infarction complicated with deep vein thrombosis （DVT） in lower limb. Methods A total of 11 patients were treated with low - molecular - weight heparin （0. 4 ml i. h. q12h , two weeks）and aspirin enteric - coated tablets （0. 3 qd, two weeks ）. Results All patients were cured except one complicated with hypodermic haemorrbage. Conclusion The anticoagulation and anti -platelet aggregation activity is a safe and valid treatment to DVT.